Description: Nanoform Finland Oyj provides nanotechnology and drug particle engineering services for the pharmaceutical industry in Europe and the United States. The company provides nanoparticle production services using its proprietary controlled expansion of supercritical solutions technology that enables clients. The company was founded in 2008 and is headquartered in Helsinki, Finland.
Home Page: www.nanoform.com
Cultivator II
Helsinki,
00790
Finland
Phone:
358 2937 00150
Officers
| Name | Title |
|---|---|
| Prof. Edward Olof Haeggstrom | Co-Founder & CEO |
| Mr. Albert Alexander Haeggstrom | CFO & Director |
| Dr. Niklas Sandler | Chief Technology Officer |
| Mr. Henri von Haartman | Director of Investor Relations |
| Mr. Peter Hanninen | Gen. Counsel |
| Ms. Johanna Tuomisto M.Soc.Sc. | Director of HR |
| Dr. David Rowe | Head of Manufacturing |
| Mr. Christian Jones | Chief Commercial Officer |
Exchange: HE
Country: FI
Currency: Euro (€)
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 0 |
| Price-to-Book MRQ: | 2.8482 |
| Price-to-Sales TTM: | 84.4347 |
| IPO Date: | |
| Fiscal Year End: | December |
| Full Time Employees: | 143 |